An Autophagy-Related Gene Signature can Better Predict Prognosis and Resistance in Diffuse Large B-Cell Lymphoma

Background: Diffuse large B-cell lymphoma (DLBCL) is a highly heterogeneous disease, and about 30%–40% of patients will develop relapsed/refractory DLBCL. In this study, we aimed to develop a gene signature to predict survival outcomes of DLBCL patients based on the autophagy-related genes (ARGs). M...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xuan, He, Ying-Zhi, Liu, Dan, Lin, Chao-Ran, Liang, Dan, Huang, Rui, Wang, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280409/
https://www.ncbi.nlm.nih.gov/pubmed/35846146
http://dx.doi.org/10.3389/fgene.2022.862179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280409/
https://www.ncbi.nlm.nih.gov/pubmed/35846146
http://dx.doi.org/10.3389/fgene.2022.862179

Ejemplares similares